HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation.

Yeung, Angie; Bhargava, Rishi K; Ahn, Raphael; Bahna, Sarra; Kang, Na Hyea; Lacoul, Ayush; Niles, Lennard P

Yeung, Angie; Bhargava, Rishi K; Ahn, Raphael; Bahna, Sarra; Kang, Na Hyea; Lacoul, Ayush; Niles, Lennard P.

Affiliation

Yeung A; Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada.

Biomed Pharmacother ; 66(3): 232-6, 2012 Apr.

Article in En | MEDLINE | ID: mdl-22436652

Subject(s)

Antineoplastic Agents/pharmacology; Breast Neoplasms/drug therapy; Histone Deacetylase Inhibitors/pharmacology; Hydroxamic Acids/pharmacology; Apoptosis/drug effects; Apoptosis Regulatory Proteins/genetics; Breast Neoplasms/genetics; Breast Neoplasms/pathology; Cell Cycle Proteins/genetics; Cell Line, Tumor; Cell Proliferation/drug effects; Cyclin-Dependent Kinase Inhibitor p21/genetics; Female; Humans; Proto-Oncogene Proteins/genetics; Tumor Suppressor Protein p53/genetics; Vorinostat; bcl-2-Associated X Protein/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Histone Deacetylase Inhibitors / Hydroxamic Acids / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Biomed Pharmacother Year: 2012 Document type: Article Affiliation country: Canada Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google